NEURALINK TRIAL
Elon Musk's Neuralink says it has 21 participants enrolled in trials
This marks an increase from the 12 people the company in September said had received its chips and were using them to control digital and physical tools through thought.
Elon Musk's Neuralink could fetch $8.5 billion valuation
Elon Musk’s Neuralink is in early talks to raise about $500 million at a pre-money valuation of $8.5 billion, a sharp rise from its $5 billion valuation in 2023. Neuralink’s brain implant, now in clinical trials, has enabled a paralysed patient to control devices using only brain signals
US FDA asks fired scientists to return, including some reviewing Elon Musk's Neuralink
At least 11 employees working at the FDA's Center for Devices and Radiological Health - which oversees medical device reviews - have received calls since Friday saying they could return to work on Monday, according to eight FDA sources who spoke under condition of anonymity. Some of the sources were told the FDA would continue making requests to return throughout the weekend.
US DOGE layoffs hit FDA staff reviewing Elon Musk’s Neuralink — What happens next?
A wave of federal job cuts initiated by the Department of Government Efficiency (DOGE) is impacting regulatory agencies investigating Elon Musk’s companies, including the US Food and Drug Administration (FDA). Employees responsible for overseeing Neuralink’s clinical trial applications were among those dismissed. With staffing reductions slowing down or bypassing regulatory oversight, concerns are growing over potentially weakened safety reviews for Musk’s ventures.
FDA staff reviewing Musk's Neuralink were included in DOGE employee firings, sources say
Approximately 20 FDA employees reviewing Neuralink's brain implant applications were dismissed amid a federal workforce purge. The cuts, attributed to performance reasons, will significantly impact the agency’s ability to process medical device applications, raising concerns about the integrity of Neuralink's ongoing trials and participant safety.
Elon Musk's Neuralink to launch feasibility trial with brain implant, robotic arm
In the United States, Neuralink has already implanted the device in two patients. It has allowed the first patient to play video games, browse the internet, post on social media and move a cursor on his laptop.
- Go To Page 1
Elon Musk's Neuralink gets FDA breakthrough device tag for 'Blindsight' implant
Elon Musk's Neuralink has received the FDA's breakthrough device designation for its experimental brain-chip implant, Blindsight, aimed at restoring vision. The device could help even those who have lost both eyes and their optic nerve. Neuralink is also testing another implant to aid paralyzed patients in using digital devices by thought alone.
Elon Musk's Neuralink seeks to enroll three patients in brain implant study
Neuralink, Elon Musk's brain-chip company, is conducting a study to evaluate its device for paralyzed patients to control digital devices through thoughts alone, facing criticism for lack of study information sharing.
US lawmaker seeks answers on FDA inspection of Musk's Neuralink
Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer using only their thoughts.
Elon Musk's Neuralink cited by FDA over animal lab issues
The inspectors identified quality control lapses at the company's California animal research facility. A similar inspection at Neuralink's Texas facility did not find problems, according to agency records. Those visits took place last year from June 12-22, and represent the FDA's sole inspections of Neuralink facilities on record.
Neuralink's first human patient able to control mouse through thinking: Elon Musk
The study uses a robot to surgically place a brain-computer interface implant in a region of the brain that controls the intention to move, Neuralink has said, adding that the initial goal is to enable people to control a computer cursor or keyboard using their thoughts.
Neuralink has put its first chip in a human brain—What could possibly go wrong?
In the past few years, Neuralink has faced investigation for mistreatment of lab animals and seen the departure of several company executives. Nevertheless, the PRIME trial is a significant milestone for a company less than ten years old. However, Neuralink's challenges are far from over. Implanting a device is just the beginning of a decades-long clinical project beset with competitors, financial hurdles and ethical quandaries.
Want details on Elon Musk's brain implant trial? You'll have to ask him
Neuralink does not have to divulge even basic details about its trial, including the facility where patients are being implanted with the device and monitored, as well as the number of participants and expected completion date.
What is the chip Elon Musk plans to implant in the human brain?
Neuralink, Elon Musk's brain implant venture, gains FDA approval for human trials. The groundbreaking "Telepathy" technology aims to restore limb functionality through thought control. Amid ethical concerns, including animal welfare investigations, Elon Musk envisions merging humans with machines. Forbes values Musk at $210.2 billion, accentuating the significance of Neuralink's strides in brain-computer interfaces. The journey into uncharted neurotechnology territory prompts crucial ethical dialogues, reshaping the future implications of restoring lost functions and enhancing human capabilities.
Elon Musk's Neuralink implants brain chip in first human: All you need to know
Neuralink achieves first successful human implantation with promising neuron spike detection. Initial users of Telepathy will be those who have lost limb use. Other companies like Synchron, Precision Neuroscience, Paradromics, and Blackrock Neurotech also have similar abilities. FDA cleared Neuralink for its human trial.
Neuralink: Here is Why US Lawmakers Are Asking SEC to Launch Fraud Investigation Into Elon Musk
Four U.S. lawmakers, including Democratic House Reps. Earl Blumenauer, Jim McGovern, Barbara Lee, and Tony Cardenas, have called on the Securities and Exchange Commission (SEC) to probe Elon Musk for potential securities fraud related to safety concerns surrounding Neuralink's brain implant.
Elon Musk's Neuralink seeks first human volunteer for groundbreaking brain chip implant trial
The company is actively searching for a human volunteer, ideally a quadriplegic under 40, willing to undergo a revolutionary brain implant procedure.
Here's how Elon Musk's Neuralink will aid paralyzed people; begins groundbreaking human trials
Elon Musk's Neuralink has gained approval to begin its first human clinical trial for its brain-computer interface implant. Known as the "PRIME Study," the trial aims to evaluate the safety and functionality of Neuralink's implant and surgical robot. The goal is to enable individuals with paralysis to control external devices using their thoughts. This milestone follows the FDA's previous refusal to allow Neuralink to implant a brain chip in humans.
Elon Musk's Neuralink raises $280 million in latest fundraise
Elon Musk's brain chip startup Neuralink has raised $280 million in a funding round led by Founders Fund, the company said in a post on messaging platform X.
Musk expects brain chip startup Neuralink to implant 'first case' this year
Last month, Neuralink said it received US Food and Drug Administration (FDA) clearance for its first-in-human clinical trial, a critical milestone for the startup as it faces US probes over its handling of animal experiments.
Elon Musk's Neuralink valued at about $5 billion despite long road to market
Elon Musk has expressed grand ambitions for Neuralink, saying its chip would allow healthy and disabled people alike to pop into neighborhood facilities for speedy surgical insertions of devices to treat obesity, autism, depression and schizophrenia.
Elon Musk's Neuralink gets nod to put chip inside human brain, Twitter says it's 'bigger for humanity than ChatGPT’
With the FDA approval out of the way, Musk's Neuralink can now implant actual humans in their heads with Neuralink device.
At Musk's brain-chip startup, animal testing panel is rife with potential conflicts
Elon Musk's brain-implant venture has filled an animal-research oversight board with company insiders who may stand to benefit financially as the firm reaches development goals.
Elon Musk's brain implant company in search of human trials partner
Neuralink has been developing brain implants since 2016 it hopes will eventually be a cure for intractable conditions such as paralysis and blindness.
Why US regulators rejected Elon Musk’s bid to test brain chips in humans
A year after the rejection, Neuralink is still working through the agency’s concerns. Three staffers said they were skeptical the company could quickly resolve the issues – despite Musk’s latest prediction at a Nov. 30 presentation that the company would secure FDA human-trial approval this spring.
What does Elon Musk's brain chip company Neuralink do?
Neuralink, the Elon Musk company that Reuters reported on Monday is the target of a federal investigation over its animal trial program, has been trying to develop a brain chip that would enable the paralyzed to walk and the blind to see.
Elon Musk says Neuralink's brain chip is finally ready for human trials, initial focus to be on restoring vision
Previously, Musk's company conducted several tests on pigs and monkeys.
Elon Musk expects Neuralink's brain chip to begin human trials in 6 months
Neuralink is developing brain chip interfaces that it says could enable disabled patients to move and communicate again, with Musk adding on Wednesday that it will also target restoring vision.
Elon Musk expects his brain chip company Neuralink to begin human trials in six months
The company is developing brain chip interfaces that it says could enable disabled patients to move and communicate again. Based in the San Francisco Bay Area and Austin, Texas, Neuralink has in recent years been conducting tests on animals as it seeks U.S. regulatory approval to begin clinical trials in people.
Load More
